Motors the pivot from Ms was because the RRMS field was over crowded they showed intent to move into SPMS but because we had no trial Data in the SPMS field it meant we had to do a carry over change in tack
ie 50-50 in patients ie 50% RRMS 50% SPMS
even though they had said they were going to drop RRMS to carry the trial this was the requirement we were going to do a trial with patients that we had no intention of taking the drug any further with
This then put us in the position we have always been in as long as i have been here.
That situation was lack of funding we just did not have the backing to do such a trial
story of ANPs life and that was the end of that, had to reinvent into something we could afford lol
Big welcome back Kev its been a while hope you manage to recover some of your past losses in this
Motors the pivot from Ms was because the RRMS field was over...
Add to My Watchlist
What is My Watchlist?
